UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The actions of relaxin on the human cardiovascular system

British journal of pharmacology, 2017-05, Vol.174 (10), p.933-949

2017

Volltextzugriff (PDF)

Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease

Circulation (New York, N.Y.), 2020-04, Vol.141 (17), p.1393-1403

2020

Volltextzugriff (PDF)

Guidelines for experimental models of myocardial ischemia and infarction

American journal of physiology. Heart and circulatory physiology, 2018-04, Vol.314 (4), p.H812-H838

2018

Volltextzugriff (PDF)

β‐Adrenoceptor activation affects galectin‐3 as a biomarker and therapeutic target in heart disease

British journal of pharmacology, 2019-07, Vol.176 (14), p.2449-2464

2019

Volltextzugriff (PDF)

Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (43), p.17615-17620

2012

Volltextzugriff (PDF)

Cardiac β‐adrenergic receptor activation mediates distinct and cell type‐dependent changes in the expression and distribution of connexin 43

Journal of cellular and molecular medicine, 2020-08, Vol.24 (15), p.8505-8517

2020

Volltextzugriff (PDF)

Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites

Nature communications, 2017-01, Vol.8 (1), p.14188-14188, Article 14188

2017

Volltextzugriff (PDF)

Stimulation of β‐adrenoceptors up‐regulates cardiac expression of galectin‐3 and BIM through the Hippo signalling pathway

British journal of pharmacology, 2019-07, Vol.176 (14), p.2465-2481

2019

Volltextzugriff (PDF)

Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure

Scientific reports, 2018-05, Vol.8 (1), p.8213-12, Article 8213

2018

Volltextzugriff (PDF)

Hippo pathway activation mediates chemotherapy-induced anti-cancer effect and cardiomyopathy through causing mitochondrial damage and dysfunction

Theranostics, 2023, Vol.13 (2), p.560-577

2023

Volltextzugriff (PDF)

Improving the quality of preclinical research echocardiography: observations, training, and guidelines for measurement

American journal of physiology. Heart and circulatory physiology, 2018-07, Vol.315 (1), p.H58-H70

2018

Volltextzugriff (PDF)

Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice

Nature communications, 2017-02, Vol.8 (1), p.14232-14232, Article 14232

2017

Volltextzugriff (PDF)

Chromatin modifications remodel cardiac gene expression

Cardiovascular research, 2014-07, Vol.103 (1), p.7-16

2014

Volltextzugriff (PDF)

HMGB1 Induces Secretion of Matrix Vesicles by Macrophages to Enhance Ectopic Mineralization

PloS one, 2016-05, Vol.11 (5), p.e0156686-e0156686

2016

Volltextzugriff (PDF)

HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes

Epigenetics, 2015-05, Vol.10 (5), p.418-430

2015

Volltextzugriff (PDF)

Relaxin mitigates microvascular damage and inflammation following cardiac ischemia–reperfusion

Basic research in cardiology, 2019-07, Vol.114 (4), p.30-15, Article 30

2019

Volltextzugriff (PDF)

Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy

PloS one, 2014-02, Vol.9 (2), p.e90337-e90337

2014

Volltextzugriff (PDF)

Association between heart rate variability indices and features of spontaneous ventricular tachyarrhythmias in mice

Clinical and experimental pharmacology & physiology, 2020-07, Vol.47 (7), p.1193-1202

2020

Volltextzugriff (PDF)

Transcriptomic Analysis of Dysregulated Genes of the nDNA-mtDNA Axis in a Mouse Model of Dilated Cardiomyopathy

Frontiers in genetics, 2022-06, Vol.13, p.921610-921610

2022

Volltextzugriff (PDF)

Cardiac rupture complicating acute myocardial infarction: the clinical features from an observational study and animal experiment

BMC cardiovascular disorders, 2020-09, Vol.20 (1), p.409-409, Article 409

2020

Volltextzugriff (PDF)

Activation of Hippo signaling pathway mediates mitochondria dysfunction and dilated cardiomyopathy in mice

Theranostics, 2021-01, Vol.11 (18), p.8993-9008

2021

Volltextzugriff (PDF)

Pro-inflammatory action of MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells

PloS one, 2013-10, Vol.8 (10), p.e76206-e76206

2013

Volltextzugriff (PDF)

Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy

Diabetes (New York, N.Y.), 2010-06, Vol.59 (6), p.1512-1520

2010

Volltextzugriff (PDF)

Manipulation of the gut microbiota by the use of prebiotic fibre does not override a genetic predisposition to heart failure

Scientific reports, 2020-10, Vol.10 (1), p.17919-17919, Article 17919

2020

Volltextzugriff (PDF)

1 – 25 von 900

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(805)
Mit Volltextzugriff
(807)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology

The actions of relaxin on the human cardiovascular system

Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease

Guidelines for experimental models of myocardial ischemia and infarction

β‐Adrenoceptor activation affects galectin‐3 as a biomarker and therapeutic target in heart disease

Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function

Cardiac β‐adrenergic receptor activation mediates distinct and cell type‐dependent changes in the expression and distribution of connexin 43

Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites

Stimulation of β‐adrenoceptors up‐regulates cardiac expression of galectin‐3 and BIM through the Hippo signalling pathway

Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure

Hippo pathway activation mediates chemotherapy-induced anti-cancer effect and cardiomyopathy through causing mitochondrial damage and dysfunction

Improving the quality of preclinical research echocardiography: observations, training, and guidelines for measurement

Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice

Chromatin modifications remodel cardiac gene expression

HMGB1 Induces Secretion of Matrix Vesicles by Macrophages to Enhance Ectopic Mineralization

HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes

Relaxin mitigates microvascular damage and inflammation following cardiac ischemia–reperfusion

Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy

Association between heart rate variability indices and features of spontaneous ventricular tachyarrhythmias in mice

Transcriptomic Analysis of Dysregulated Genes of the nDNA-mtDNA Axis in a Mouse Model of Dilated Cardiomyopathy

Cardiac rupture complicating acute myocardial infarction: the clinical features from an observational study and animal experiment

Activation of Hippo signaling pathway mediates mitochondria dysfunction and dilated cardiomyopathy in mice

Pro-inflammatory action of MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells

Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy

Manipulation of the gut microbiota by the use of prebiotic fibre does not override a genetic predisposition to heart failure

Aktive Filter

Suchergebnisse filtern